All Marketing authorization holders of medicine are hereby informed that 74th Medicines Evaluation Committee held on 24th January 2023 recommended not to register new products of Levofloxacin Eye/Ear drops and not to renew or issue import license for existing Levofloxacin Eye/Ear drops.

(Date : 18 April 2023)

‍